U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C27H33N9O15P2
Molecular Weight 785.5497
Optical Activity UNSPECIFIED
Defined Stereocenters 7 / 7
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of FLAVIN ADENINE DINUCLEOTIDE

SMILES

CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)COP(O)(=O)OP(O)(=O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)N4C=NC5=C4N=CN=C5N)C6=NC(=O)NC(=O)C6=N2

InChI

InChIKey=VWWQXMAJTJZDQX-UYBVJOGSSA-N
InChI=1S/C27H33N9O15P2/c1-10-3-12-13(4-11(10)2)35(24-18(32-12)25(42)34-27(43)33-24)5-14(37)19(39)15(38)6-48-52(44,45)51-53(46,47)49-7-16-20(40)21(41)26(50-16)36-9-31-17-22(28)29-8-30-23(17)36/h3-4,8-9,14-16,19-21,26,37-41H,5-7H2,1-2H3,(H,44,45)(H,46,47)(H2,28,29,30)(H,34,42,43)/t14-,15+,16+,19-,20+,21+,26+/m0/s1

HIDE SMILES / InChI

Molecular Formula C27H33N9O15P2
Molecular Weight 785.5497
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 7 / 7
E/Z Centers 0
Optical Activity UNSPECIFIED

Description
Curator's Comment: description was created based on several sources, including: http://www.wikidoc.org/index.php/FAD http://www.drugbank.ca/drugs/DB03147

Flavin adenine dinucleotide is a coenzyme form of vitamin B2. Many oxidoreductases, called flavoenzymes or flavoproteins, require FAD as a prosthetic group, which functions in electron transfers. It is usually used for the prevention and treatment of various diseases that are caused by Vitamin B2 deficiency or metabolic disorder including stomatitis, eczema, etc. No adverse reactions were reported.

Approval Year

TargetsConditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Palliative
Flavitan

Approved Use

It is usually used for the prevention and treatment of various diseases that are caused by Vitamin B2 deficiency

Launch Date

1966
Palliative
Flavitan

Approved Use

It is an effective in conjunctivitis treatment.

Launch Date

1966
Palliative
Flavitan

Approved Use

It is usually used for the prevention and treatment of metabolic disorder including stomatitis.

Launch Date

1966
PubMed

PubMed

TitleDatePubMed
Towards a systematic analysis of human short-chain dehydrogenases/reductases (SDR): Ligand identification and structure-activity relationships.
2015-06-05
Involvement of riboflavin kinase expression in cellular sensitivity against cisplatin.
2011-04
Identification and functional characterization of rat riboflavin transporter 2.
2009-04
Coordinated and reversible reduction of enzymes involved in terminal oxidative metabolism in skeletal muscle mitochondria from a riboflavin-responsive, multiple acyl-CoA dehydrogenase deficiency patient.
2006-03
Architecture of succinate dehydrogenase and reactive oxygen species generation.
2003-01-31
Enzymatic and non-enzymatic reduction of brucine N-oxide by aldehyde oxidase and catalase.
2001-11
Mammalian augmenter of liver regeneration protein is a sulfhydryl oxidase.
2001-03
Cloning, heterologous expression, and enzymological characterization of human squalene monooxygenase.
2000-02-15
Structure of fumarate reductase from Wolinella succinogenes at 2.2 A resolution.
1999-11-25
Determination of riboflavin and flavocoenzymes in human blood plasma by high-performance liquid chromatography.
1995
Flavin adenine dinucleotide levels in erythrocytes of very low birthweight infants under vitamin supplementation.
1993
[Comparison of biochemical criteria for supplying the human body with riboflavin].
1991-09-01
Nutritional status in anorexia nervosa: clinical chemistry, vitamins, iron and zinc.
1988-11
Riboflavin metabolism in the hypothyroid newborn.
1988-03
Quantification of riboflavin, riboflavin 5'-phosphate and flavin adenine dinucleotide in plasma and urine by high-performance liquid chromatography.
1987-12-25
Riboflavin metabolism in the hypothyroid human adult.
1987-02
ACP1GUA-1--a low-activity variant of human erythrocyte acid phosphatase: association with increased glutathione reductase activity.
1982-05
Mechanism of chlorpromazine-induced arrhythmia -- arrhythmia and mitochondrial dysfunction.
1981-07
Protection of chlorpromazine-induced arrhythmia by flavin-adenine-dinucleotide in canine heart.
1979-09
Flavin adenine dinucleotide concentration in erythrocytes with normal and deficient glucose-6-phosphate dehydrogenase.
1970-09-01
Patents

Patents

Sample Use Guides

Oral: Take 5 to 45 mg of flavin adenine dinucleotide per day in 1 to 3 divided doses. Injection: 40 mg one or two times per day
Route of Administration: Other
In Vitro Use Guide
The addition of 1uM of FAD was found to exert a consistent activation effect on Glutathione reductase activity.
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:49:04 GMT 2025
Edited
by admin
on Mon Mar 31 18:49:04 GMT 2025
Record UNII
ZC44YTI8KK
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
FLAVIN ADENINE DINUCLEOTIDE
JAN  
Common Name English
FLAVINE ADENINE DINUCLEOTIDE
WHO-DD  
Preferred Name English
ADENINE-RIBOFLAVIN DINUCLEOTIDE
Common Name English
FLAVIN-ADENINE DINUCLEOTIDE [MI]
Common Name English
RIBOFLAVINE 5'-(TRIHYDROGEN DIPHOSPHATE) 5'->5'-ESTER WITH ADENOSINE
Common Name English
FLAVINE ADENOSINE DIPHOSPHATE
Common Name English
FLAVIN ADENIN DINUCLEOTIDE
Common Name English
NSC-112207
Code English
RIBOFLAVIN 5'-ADENOSINE DIPHOSPHATE
Common Name English
FAD
Brand Name English
FLAVINE-ADENINE DINUCLEOTIDE
Common Name English
Flavine adenine dinucleotide [WHO-DD]
Common Name English
RIBOFLAVIN 5'-(TRIHYDROGEN DIPHOSPHATE), P'->5'-ESTER WITH ADENOSINE
Common Name English
Classification Tree Code System Code
LOINC 53647-4
Created by admin on Mon Mar 31 18:49:04 GMT 2025 , Edited by admin on Mon Mar 31 18:49:04 GMT 2025
LOINC 78991-7
Created by admin on Mon Mar 31 18:49:04 GMT 2025 , Edited by admin on Mon Mar 31 18:49:04 GMT 2025
LOINC 78990-9
Created by admin on Mon Mar 31 18:49:04 GMT 2025 , Edited by admin on Mon Mar 31 18:49:04 GMT 2025
LOINC 2281-4
Created by admin on Mon Mar 31 18:49:04 GMT 2025 , Edited by admin on Mon Mar 31 18:49:04 GMT 2025
NCI_THESAURUS C26017
Created by admin on Mon Mar 31 18:49:04 GMT 2025 , Edited by admin on Mon Mar 31 18:49:04 GMT 2025
Code System Code Type Description
CAS
146-14-5
Created by admin on Mon Mar 31 18:49:04 GMT 2025 , Edited by admin on Mon Mar 31 18:49:04 GMT 2025
PRIMARY
DAILYMED
ZC44YTI8KK
Created by admin on Mon Mar 31 18:49:04 GMT 2025 , Edited by admin on Mon Mar 31 18:49:04 GMT 2025
PRIMARY
DRUG BANK
DB03147
Created by admin on Mon Mar 31 18:49:04 GMT 2025 , Edited by admin on Mon Mar 31 18:49:04 GMT 2025
PRIMARY
CHEBI
16238
Created by admin on Mon Mar 31 18:49:04 GMT 2025 , Edited by admin on Mon Mar 31 18:49:04 GMT 2025
PRIMARY
MERCK INDEX
m5392
Created by admin on Mon Mar 31 18:49:04 GMT 2025 , Edited by admin on Mon Mar 31 18:49:04 GMT 2025
PRIMARY Merck Index
ECHA (EC/EINECS)
205-663-1
Created by admin on Mon Mar 31 18:49:04 GMT 2025 , Edited by admin on Mon Mar 31 18:49:04 GMT 2025
PRIMARY
FDA UNII
ZC44YTI8KK
Created by admin on Mon Mar 31 18:49:04 GMT 2025 , Edited by admin on Mon Mar 31 18:49:04 GMT 2025
PRIMARY
EPA CompTox
DTXSID4048307
Created by admin on Mon Mar 31 18:49:04 GMT 2025 , Edited by admin on Mon Mar 31 18:49:04 GMT 2025
PRIMARY
EVMPD
SUB13892MIG
Created by admin on Mon Mar 31 18:49:04 GMT 2025 , Edited by admin on Mon Mar 31 18:49:04 GMT 2025
PRIMARY
WIKIPEDIA
FLAVIN ADENINE DINUCLEOTIDE
Created by admin on Mon Mar 31 18:49:04 GMT 2025 , Edited by admin on Mon Mar 31 18:49:04 GMT 2025
PRIMARY
SMS_ID
100000078499
Created by admin on Mon Mar 31 18:49:04 GMT 2025 , Edited by admin on Mon Mar 31 18:49:04 GMT 2025
PRIMARY
PUBCHEM
643975
Created by admin on Mon Mar 31 18:49:04 GMT 2025 , Edited by admin on Mon Mar 31 18:49:04 GMT 2025
PRIMARY
NCI_THESAURUS
C80888
Created by admin on Mon Mar 31 18:49:04 GMT 2025 , Edited by admin on Mon Mar 31 18:49:04 GMT 2025
PRIMARY
RXCUI
1314412
Created by admin on Mon Mar 31 18:49:04 GMT 2025 , Edited by admin on Mon Mar 31 18:49:04 GMT 2025
PRIMARY
ChEMBL
CHEMBL1232653
Created by admin on Mon Mar 31 18:49:04 GMT 2025 , Edited by admin on Mon Mar 31 18:49:04 GMT 2025
PRIMARY
NSC
112207
Created by admin on Mon Mar 31 18:49:04 GMT 2025 , Edited by admin on Mon Mar 31 18:49:04 GMT 2025
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
Related Record Type Details
ACTIVE MOIETY